09.08.25 -- Delve Into The Role Of Process Intensification In mAb Manufacturing

Process intensification is poised to transform monoclonal antibody (mAb) manufacturing by introducing innovative, scalable strategies that significantly enhance efficiency. In this comprehensive white paper you can explore how streamlining production workflows and integrating advanced technologies can dramatically boost productivity and reduce operational costs.

Watch this webinar to discover how your facility’s layout and process flow may be limiting its efficiency, as well as gain insights into media requirements in upstream and downstream processing (USP and DSP) to enhance scheduling and optimize your footprint for more effective media management.

A large biopharma company wanted to establish a single-use multi-product facility by choosing appropriate upstream processes that can deliver more than 500 kg/year throughput. This case study shows how a concentrated fed-batch process was established, enabling higher productivity and increasing the throughput.

Process intensification is revolutionizing industries today by driving efficiency and sustainability. Experts and early adopters are actively addressing challenges and leveraging innovative technologies to unlock new levels of performance. See how this transformative approach is reshaping operations and setting new standards.

The biopharmaceutical industry is rapidly evolving, prompting manufacturers to reduce costs and enhance productivity. Find out why process intensification offers a powerful solution by streamlining operations and improving efficiency to optimize performance and help secure a more resilient and competitive future.